Skip to main content
. 2020 Mar 28;8(4):72. doi: 10.3390/biomedicines8040072
cPRA calculated panel-reactive antibody
dnDSA de novo donor-specific antibodies
CNI calcineurin inhibitor
MMF mycophenolate mofetil
MPA mycophenolic acid
CKD chronic kidney disease
HTN hypertension
RRT renal replacement therapy
HD hemodialysis
PD peritoneal dialysis
DBD brain death donors
DCD circulatory death donors
RBCC red blood cell concentrates